Οξεία μυελογενής λευχαιμία (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Οξεία μυελογενής λευχαιμία" in Greek language version.

refsWebsite

Global rank Greek rank

64nih.gov

4^th place

38doi.org

2^nd place

3^rd place

24web.archive.org

1^st place

19hematologylibrary.org

low place

3,181^st place

11archive.org

6^th place

5^th place

4ascopubs.org

low place

2amcancersoc.org

low place

2harvard.edu

18^th place

57^th place

2nejm.org

2,374^th place

2,218^th place

2nature.com

234^th place

207^th place

1medscape.com

719^th place

579^th place

1mountsinai.org

low place

9,441^st place

1haematologica.org

low place

amcancersoc.org

caonline.amcancersoc.org

Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA Cancer J Clin 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-01-28. https://web.archive.org/web/20110128054629/http://caonline.amcancersoc.org/cgi/content/full/52/1/23. Ανακτήθηκε στις 2011-11-27.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA Cancer J Clin 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-07-06. https://web.archive.org/web/20100706234501/http://caonline.amcancersoc.org/cgi/content/full/51/1/15. Ανακτήθηκε στις 2011-11-30.

archive.org

Yoshinaga S, Mabuchi K, Sigurdson A, Doody M, Ron E (2004). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology 233 (2): 313–21. doi:10.1148/radiol.2332031119. PMID 15375227. https://archive.org/details/sim_radiology_2004-11_233_2/page/313.
Taylor GM, Birch JM (1996). «The hereditary basis of human leukemia». Στο: Henderson ES, Lister TA, Greaves MF. Leukemia (6th έκδοση). Philadelphia: WB Saunders. σελ. 210. ISBN 0-7216-5381-2. CS1 maint: Πολλαπλές ονομασίες: editors list (link)
Horwitz M, Goode EL, Jarvik GP (1996). «Anticipation in familial leukemia». Am. J. Hum. Genet. 59 (5): 990–8. PMID 8900225. PMC 1914843. https://archive.org/details/sim_american-journal-of-human-genetics_1996-11_59_5/page/990. Πλήρες κείμενο στο PMC: 1914843
Gunz FW, Veale AM (1969). «Leukemia in close relatives--accident or predisposition?». J. Natl. Cancer Inst. 42 (3): 517–24. PMID 4180615. https://archive.org/details/sim_journal-of-the-national-cancer-institute_1969-03_42_3/page/517.
Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999). «The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997». Ann Oncol 10 (12): 1419–32. doi:10.1023/A:1008375931236. PMID 10643532. https://archive.org/details/sim_annals-of-oncology_1999-12_10_12/page/1419.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E (1996). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». Br J Haematol 94 (3): 557–73. PMID 8790159. https://archive.org/details/sim_british-journal-of-haematology_1996-09_94_3/page/557.
Bishop J (1997). «The treatment of adult acute myeloid leukemia». Semin Oncol 24 (1): 57–69. PMID 9045305. https://archive.org/details/sim_seminars-in-oncology_1997-02_24_1/page/57.
Wheatley K, Burnett A, Goldstone A, Gray R, Hann I, Harrison C, Rees J, Stevens R, Walker Η (1999). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». Br J Haematol 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. https://archive.org/details/sim_british-journal-of-haematology_1999-10_107_1/page/69.
Matthews JP, Bishop JF, Young GA, Juneja, S. K., Lowenthal, R. M., Garson, O. M., Cobcroft, R. G., Dodds, A. J. και άλλοι. (2001). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». Br. J. Haematol. 113 (3): 727–36. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. https://archive.org/details/sim_british-journal-of-haematology_2001-06_113_3/page/727.
Linet MS (1985). «The leukemias: Epidemiologic aspects.». Στο: Lilienfeld AM. Monographs in Epidemiology and Biostatistics. New York: Oxford University Press. σελ. I. ISBN 0-19-503448-1.
Virchow, R (1856). «Die Leukämie». Στο: Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin (στα German). Frankfurt: Meidinger. σελ. 190. CS1 maint: Μη αναγνωρίσιμη γλώσσα (link)

ascopubs.org

jco.ascopubs.org

Sievers EL, Larson RA, Stadtmauer EA, Estey, E, Löwenberg, B, Dombret, Η, Karanes, C, Theobald, M και άλλοι. (1 Ιουλίου 2001). «Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse». J. Clin. Oncol. 19 (13): 3244–54. PMID 11432892. http://jco.ascopubs.org/cgi/content/full/19/13/3244.
Soignet SL, Frankel SR, Douer D, Tallman, MS, Kantarjian, Η, Calleja, E, Stone, RM, Kalaycio, M και άλλοι. (15 Σεπτεμβρίου 2001). «United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia». J. Clin. Oncol. 19 (18): 3852–60. PMID 11559723. http://jco.ascopubs.org/cgi/content/full/19/18/3852.
Haferlach T, Schoch C, Löffler Η, Gassmann, W, Kern, W, Schnittger, S, Fonatsch, C, Ludwig, WD και άλλοι. (2003). «Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies». J. Clin. Oncol. 21 (2): 256–65. doi:10.1200/JCO.2003.08.005. PMID 12525517. http://jco.ascopubs.org/cgi/content/full/21/2/256.
Paschka P, Marcucci G, Ruppert AS, Mrózek, K, Chen, Η, Kittles, RA, Vukosavljevic, T, Perrotti, D και άλλοι. (2006). «Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study». J. Clin. Oncol. 24 (24): 3904–11. doi:10.1200/JCO.2006.06.9500. PMID 16921041. http://jco.ascopubs.org/cgi/content/full/24/24/3904.

doi.org

dx.doi.org

Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA Cancer J Clin 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-01-28. https://web.archive.org/web/20110128054629/http://caonline.amcancersoc.org/cgi/content/full/52/1/23. Ανακτήθηκε στις 2011-11-27.
Vardiman JW, Harris NL, Brunning RD (2002). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood 100 (7): 2292–302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217161643/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/7/2292. Ανακτήθηκε στις 2011-11-28.
Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). «Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group». Br J Haematol 33 (4): 451–8. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440.
Thirman M, Gill H, Burnett R, Mbangkollo D, McCabe N, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg A (1993). «Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations». N Engl J Med 329 (13): 909–14. doi:10.1056/NEJM199309233291302. PMID 8361504.
Bizzozero O, Johnson K, Ciocco A (1966). «Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time». N Engl J Med 274 (20): 1095–101. doi:10.1056/NEJM196605192742001. PMID 5932020.
Yoshinaga S, Mabuchi K, Sigurdson A, Doody M, Ron E (2004). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology 233 (2): 313–21. doi:10.1148/radiol.2332031119. PMID 15375227. https://archive.org/details/sim_radiology_2004-11_233_2/page/313.
Crittenden LB (1961). «An interpretation of familial aggregation based on multiple genetic and environmental factors». Ann. N. Y. Acad. Sci. 91 (3): 769–80. doi:10.1111/j.1749-6632.1961.tb31106.x. PMID 13696504. Bibcode: 1961NYASA..91..769C.
Horwitz M (1997). «The genetics of familial leukemia». Leukemia 11 (8): 1347–59. doi:10.1038/sj.leu.2400707. PMID 9264391.
Evans D, Steward J (1972). «Down's syndrome and leukaemia». Lancet 2 (7790): 1322. doi:10.1016/S0140-6736(72)92704-3. PMID 4117858.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD (Ιούνιος 2007). «Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review». Br. J. Haematol. 137 (5): 387–400. doi:10.1111/j.1365-2141.2007.06566.x. PMID 17488484.
Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999). «The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997». Ann Oncol 10 (12): 1419–32. doi:10.1023/A:1008375931236. PMID 10643532. https://archive.org/details/sim_annals-of-oncology_1999-12_10_12/page/1419.
Amin, H. M.; Yang, Y.; Shen, Y.; Estey, E. H.; Giles, F. J.; Pierce, S. A.; Kantarjian, H. M.; O'Brien, S. M. και άλλοι. (2005). «Having a higher blast percentage in circulation than bone marrow: Clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias». Leukemia 19 (9): 1567–1572. doi:10.1038/sj.leu.2403876. PMID 16049515.
Fialkow PJ (1976). «Clonal origin of human tumors». Biochim. Biophys. Acta 458 (3): 283–321. doi:10.1016/0304-419X(76)90003-2. PMID 1067873.
Bonnet D, Dick JE (1997). «Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell». Nat. Med. 3 (7): 730–7. doi:10.1038/nm0797-730. PMID 9212098.
Tallman MS, Andersen JW, Schiffer CA, Appelbaum, Frederick R., Feusner, James H., Ogden, Angela, Shepherd, Lois, Willman, Cheryl και άλλοι. (1997). «All-trans-retinoic acid in acute promyelocytic leukemia». N. Engl. J. Med. 337 (15): 1021–8. doi:10.1056/NEJM199710093371501. PMID 9321529. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-25. https://web.archive.org/web/20090925093142/http://content.nejm.org/cgi/content/full/337/15/1021. Ανακτήθηκε στις 2011-11-30.
Mayer RJ, Davis RB, Schiffer CA, Berg, Deborah T., Powell, Bayard L., Schulman, Philip, Omura, George A., Moore, Joseph O. και άλλοι. (1994). «Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B». N. Engl. J. Med. 331 (14): 896–903. doi:10.1056/NEJM199410063311402. PMID 8078551.
Brune M, Castaigne S, Catalano J, Gehlsen, K, Ho, AD, Hofmann, WK, Hogge, DE, Nilsson, B και άλλοι. (Ιούλιος 2006). «Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial». Blood 108 (1): 88–96. doi:10.1182/blood-2005-10-4073. PMID 16556892. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-03-25. https://web.archive.org/web/20100325091815/http://bloodjournal.hematologylibrary.org/cgi/content/full/108/1/88. Ανακτήθηκε στις 2011-11-30.
Appelbaum FR (2001). «Editorial: Who should be transplanted for AML?». Leukemia 15 (4): 680–2. doi:10.1038/sj/leu/2402074. PMID 11368380.
Appelbaum FR (2002). «Keynote address: hematopoietic cell transplantation beyond first remission». Leukemia 16 (2): 157–9. doi:10.1038/sj.leu.2402345. PMID 11840278. http://www.nature.com/leu/journal/v16/n2/full/2402345a.html.
Estey E (2001). «Prognostic factors in acute myelogenous leukemia». Leukemia 15 (4): 670–2. doi:10.1038/sj/leu/2402057. PMID 11368376.
Wheatley K, Burnett A, Goldstone A, Gray R, Hann I, Harrison C, Rees J, Stevens R, Walker Η (1999). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». Br J Haematol 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. https://archive.org/details/sim_british-journal-of-haematology_1999-10_107_1/page/69.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Thirman M, Larson R (1996). «Therapy-related myeloid leukemia». Hematol Oncol Clin North Am 10 (2): 293–320. doi:10.1016/S0889-8588(05)70340-3. PMID 8707757.
Pedersen-Bjergaard J, Andersen M, Christiansen D, Nerlov C (2002). «Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia». Blood 99 (6): 1909–12. doi:10.1182/blood.V99.6.1909. PMID 1877259. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204955/http://bloodjournal.hematologylibrary.org/cgi/content/full/99/6/1909. Ανακτήθηκε στις 2011-11-28.
Haferlach T, Schoch C, Löffler Η, Gassmann, W, Kern, W, Schnittger, S, Fonatsch, C, Ludwig, WD και άλλοι. (2003). «Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies». J. Clin. Oncol. 21 (2): 256–65. doi:10.1200/JCO.2003.08.005. PMID 12525517. http://jco.ascopubs.org/cgi/content/full/21/2/256.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland C, Serve H, Büchner T, Haferlach T, Hiddemann W (2002). «Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease». Blood 100 (1): 59–66. doi:10.1182/blood.V100.1.59. PMID 12070009. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-15. https://web.archive.org/web/20100515191256/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/1/59. Ανακτήθηκε στις 2011-11-28.
Gale RE, Hills R, Kottaridis PD, Srirangan, S, Wheatley, K, Burnett, AK, Linch, DC (2005). «No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials». Blood 106 (10): 3658–65. doi:10.1182/blood-2005-03-1323. PMID 16076872. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-02-09. https://web.archive.org/web/20110209110028/http://bloodjournal.hematologylibrary.org/cgi/content/full/106/10/3658. Ανακτήθηκε στις 2011-11-28.
Thornton KA, Levis M (2007). «Images in clinical medicine. FLT3 Mutation and acute myelogenous leukemia with leukostasis». N. Engl. J. Med. 357 (16): 1639. doi:10.1056/NEJMicm064764. PMID 17942876.
Paschka P, Marcucci G, Ruppert AS, Mrózek, K, Chen, Η, Kittles, RA, Vukosavljevic, T, Perrotti, D και άλλοι. (2006). «Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study». J. Clin. Oncol. 24 (24): 3904–11. doi:10.1200/JCO.2006.06.9500. PMID 16921041. http://jco.ascopubs.org/cgi/content/full/24/24/3904.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus, Hillard M., Rowe, Jacob M., Paietta, Elisabeth, Willman, Cheryl, Hurd, David D. και άλλοι. (1998). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». N. Engl. J. Med. 339 (23): 1649–56. doi:10.1056/NEJM199812033392301. PMID 9834301. Αρχειοθετήθηκε από το πρωτότυπο στις 2003-02-12. https://web.archive.org/web/20030212235731/http://content.nejm.org/cgi/content/full/339/23/1649. Ανακτήθηκε στις 2011-11-28.
Matthews JP, Bishop JF, Young GA, Juneja, S. K., Lowenthal, R. M., Garson, O. M., Cobcroft, R. G., Dodds, A. J. και άλλοι. (2001). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». Br. J. Haematol. 113 (3): 727–36. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. https://archive.org/details/sim_british-journal-of-haematology_2001-06_113_3/page/727.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA Cancer J Clin 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-07-06. https://web.archive.org/web/20100706234501/http://caonline.amcancersoc.org/cgi/content/full/51/1/15. Ανακτήθηκε στις 2011-11-30.
Bhatia S, Neglia JP (1995). «Epidemiology of childhood acute myelogenous leukemia». J. Pediatr. Hematol. Oncol. 17 (2): 94–100. doi:10.1097/00043426-199505000-00002. PMID 7749772.
Naegeli O (1900). «Über rothes Knochenmark und Myeloblasten». Deutsch Med Wochenschr 26 (18): 287. doi:10.1055/s-0029-1203820.
Zhen-yi, Wang (2003). «Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis». Hematology 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-03. https://web.archive.org/web/20111003222949/http://asheducationbook.hematologylibrary.org/cgi/content/full/2003/1/1. Ανακτήθηκε στις 2011-11-28.
Ley TJ, Mardis ER, Ding L, Fulton, Bob, McLellan, Michael D., Chen, Ken, Dooling, David, Dunford-Shore, Brian H. και άλλοι. (2008). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature 456 (7218): 66–72. doi:10.1038/nature07485. PMID 18987736. PMC 2603574. Bibcode: 2008Natur.456...66L. http://www.nature.com/nature/journal/v456/n7218/abs/nature07485.html.
Shapira T, Pereg D, Lishner M (Σεπτέμβριος 2008). «How I treat acute and chronic leukemia in pregnancy». Blood Rev. 22 (5): 247–59. doi:10.1016/j.blre.2008.03.006. PMID 18472198.

haematologica.org

Leone G, Mele L, Pulsoni A, Equitani F, Pagano L (1 Οκτωβρίου 1999). «The incidence of secondary leukemias». Haematologica 84 (10): 937–45. PMID 10509043. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-02. https://web.archive.org/web/20111002154823/http://www.haematologica.org/cgi/reprint/84/10/937. Ανακτήθηκε στις 2011-11-30.

harvard.edu

adsabs.harvard.edu

Crittenden LB (1961). «An interpretation of familial aggregation based on multiple genetic and environmental factors». Ann. N. Y. Acad. Sci. 91 (3): 769–80. doi:10.1111/j.1749-6632.1961.tb31106.x. PMID 13696504. Bibcode: 1961NYASA..91..769C.
Ley TJ, Mardis ER, Ding L, Fulton, Bob, McLellan, Michael D., Chen, Ken, Dooling, David, Dunford-Shore, Brian H. και άλλοι. (2008). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature 456 (7218): 66–72. doi:10.1038/nature07485. PMID 18987736. PMC 2603574. Bibcode: 2008Natur.456...66L. http://www.nature.com/nature/journal/v456/n7218/abs/nature07485.html.

hematologylibrary.org

bloodjournal.hematologylibrary.org

Vardiman JW, Harris NL, Brunning RD (2002). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood 100 (7): 2292–302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217161643/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/7/2292. Ανακτήθηκε στις 2011-11-28.
Fialkow PJ, Janssen JW, Bartram CR (1 Απριλίου 1991). «Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy» (PDF). Blood 77 (7): 1415–7. PMID 2009365. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205004/http://bloodjournal.hematologylibrary.org/cgi/reprint/77/7/1415. Ανακτήθηκε στις 2011-11-30.
Melnick A, Licht JD (15 Μαΐου 1999). «Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia». Blood 93 (10): 3167–215. PMID 10233871. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217143052/http://bloodjournal.hematologylibrary.org/cgi/content/full/93/10/3167. Ανακτήθηκε στις 2011-11-30.
Weick JK, Kopecky KJ, Appelbaum FR, Head, DR, Kingsbury, LL, Balcerzak, SP, Bickers, JN, Hynes, HE και άλλοι. (15 Οκτωβρίου 1996). «A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study» (PDF). Blood 88 (8): 2841–51. PMID 8874180. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205009/http://bloodjournal.hematologylibrary.org/cgi/reprint/88/8/2841. Ανακτήθηκε στις 2011-11-30.
Bishop JF, Matthews JP, Young GA, Szer, J, Gillett, A, Joshua, D, Bradstock, K, Enno, A και άλλοι. (1 Μαρτίου 1996). «A randomized study of high-dose cytarabine in induction in acute myeloid leukemia» (PDF). Blood 87 (5): 1710–7. PMID 8634416. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-04-21. https://web.archive.org/web/20090421123351/http://bloodjournal.hematologylibrary.org/cgi/reprint/87/5/1710. Ανακτήθηκε στις 2011-11-30.
Huang ME, Ye YC, Chen SR, Chai, JR, Lu, JX, Zhoa, L, Gu, LJ, Wang, ZY (1 Αυγούστου 1988). «Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia» (PDF). Blood 72 (2): 567–72. PMID 3165295. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204959/http://bloodjournal.hematologylibrary.org/cgi/reprint/72/2/567. Ανακτήθηκε στις 2011-11-30.
Fenaux P, Chastang C, Chevret S, Sanz, M, Dombret, Η, Archimbaud, E, Fey, M, Rayon, C και άλλοι. (15 Αυγούστου 1999). «A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group». Blood 94 (4): 1192–200. PMID 10438706. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-10-31. https://web.archive.org/web/20101031140014/http://bloodjournal.hematologylibrary.org/cgi/content/full/94/4/1192. Ανακτήθηκε στις 2011-11-30.
Brune M, Castaigne S, Catalano J, Gehlsen, K, Ho, AD, Hofmann, WK, Hogge, DE, Nilsson, B και άλλοι. (Ιούλιος 2006). «Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial». Blood 108 (1): 88–96. doi:10.1182/blood-2005-10-4073. PMID 16556892. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-03-25. https://web.archive.org/web/20100325091815/http://bloodjournal.hematologylibrary.org/cgi/content/full/108/1/88. Ανακτήθηκε στις 2011-11-30.
Slovak M, Kopecky K, Cassileth P, Harrington D, Theil K, Mohamed A, Paietta E, Willman C, Head D, Rowe J, Forman S, Appelbaum F (15 Δεκεμβρίου 2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164311/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/13/4075. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Grimwade D, Walker Η, Oliver F, Wheatley, K, Harrison, C, Harrison, G, Rees, J, Hann, I και άλλοι. (1 Οκτωβρίου 1998). «The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties». Blood 92 (7): 2322–33. PMID 9746770. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington, DH, Theil, KS, Mohamed, A, Paietta, E, Willman, CL και άλλοι. (2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Rowley J, Golomb H, Vardiman J (1 Οκτωβρίου 1981). «Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease». Blood 58 (4): 759–67. PMID 7272506. http://bloodjournal.hematologylibrary.org/cgi/content/full/58/4/759. ^{[νεκρός σύνδεσμος]}
Pedersen-Bjergaard J, Andersen M, Christiansen D, Nerlov C (2002). «Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia». Blood 99 (6): 1909–12. doi:10.1182/blood.V99.6.1909. PMID 1877259. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204955/http://bloodjournal.hematologylibrary.org/cgi/content/full/99/6/1909. Ανακτήθηκε στις 2011-11-28.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland C, Serve H, Büchner T, Haferlach T, Hiddemann W (2002). «Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease». Blood 100 (1): 59–66. doi:10.1182/blood.V100.1.59. PMID 12070009. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-15. https://web.archive.org/web/20100515191256/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/1/59. Ανακτήθηκε στις 2011-11-28.
Gale RE, Hills R, Kottaridis PD, Srirangan, S, Wheatley, K, Burnett, AK, Linch, DC (2005). «No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials». Blood 106 (10): 3658–65. doi:10.1182/blood-2005-03-1323. PMID 16076872. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-02-09. https://web.archive.org/web/20110209110028/http://bloodjournal.hematologylibrary.org/cgi/content/full/106/10/3658. Ανακτήθηκε στις 2011-11-28.
Sanz MA, Lo Coco F, Martín G, Avvisati, G, Rayón, C, Barbui, T, Díaz-Mediavilla, J, Fioritoni, G και άλλοι. (15 Αυγούστου 2000). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood 96 (4): 1247–53. PMID 10942364. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-27. https://web.archive.org/web/20100527064934/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/4/1247. Ανακτήθηκε στις 2011-11-28.

asheducationbook.hematologylibrary.org

Zhen-yi, Wang (2003). «Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis». Hematology 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-03. https://web.archive.org/web/20111003222949/http://asheducationbook.hematologylibrary.org/cgi/content/full/2003/1/1. Ανακτήθηκε στις 2011-11-28.

medscape.com

emedicine.medscape.com

Seiter, Karen· Jules, E Harris (20 Μαΐου 2011). «Acute Myeloid Leukemia Staging». Ανακτήθηκε στις 26 Αυγούστου 2011.

mountsinai.org

Acute myeloid leukemia Αρχειοθετήθηκε 2009-09-26 στο Wayback Machine. at Mount Sinai Hospital

nature.com

Appelbaum FR (2002). «Keynote address: hematopoietic cell transplantation beyond first remission». Leukemia 16 (2): 157–9. doi:10.1038/sj.leu.2402345. PMID 11840278. http://www.nature.com/leu/journal/v16/n2/full/2402345a.html.
Ley TJ, Mardis ER, Ding L, Fulton, Bob, McLellan, Michael D., Chen, Ken, Dooling, David, Dunford-Shore, Brian H. και άλλοι. (2008). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature 456 (7218): 66–72. doi:10.1038/nature07485. PMID 18987736. PMC 2603574. Bibcode: 2008Natur.456...66L. http://www.nature.com/nature/journal/v456/n7218/abs/nature07485.html.

nejm.org

content.nejm.org

Tallman MS, Andersen JW, Schiffer CA, Appelbaum, Frederick R., Feusner, James H., Ogden, Angela, Shepherd, Lois, Willman, Cheryl και άλλοι. (1997). «All-trans-retinoic acid in acute promyelocytic leukemia». N. Engl. J. Med. 337 (15): 1021–8. doi:10.1056/NEJM199710093371501. PMID 9321529. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-25. https://web.archive.org/web/20090925093142/http://content.nejm.org/cgi/content/full/337/15/1021. Ανακτήθηκε στις 2011-11-30.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus, Hillard M., Rowe, Jacob M., Paietta, Elisabeth, Willman, Cheryl, Hurd, David D. και άλλοι. (1998). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». N. Engl. J. Med. 339 (23): 1649–56. doi:10.1056/NEJM199812033392301. PMID 9834301. Αρχειοθετήθηκε από το πρωτότυπο στις 2003-02-12. https://web.archive.org/web/20030212235731/http://content.nejm.org/cgi/content/full/339/23/1649. Ανακτήθηκε στις 2011-11-28.

nih.gov

ncbi.nlm.nih.gov

Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA Cancer J Clin 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-01-28. https://web.archive.org/web/20110128054629/http://caonline.amcancersoc.org/cgi/content/full/52/1/23. Ανακτήθηκε στις 2011-11-27.
Vardiman JW, Harris NL, Brunning RD (2002). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood 100 (7): 2292–302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217161643/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/7/2292. Ανακτήθηκε στις 2011-11-28.
Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). «Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group». Br J Haematol 33 (4): 451–8. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440.
Sanz G, Sanz M, Vallespí T, Cañizo M, Torrabadella M, García S, Irriguible D, San Miguel J (1989). «Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients». Blood 74 (1): 395–408. PMID 2752119.
Le Beau M, Albain K, Larson R, Vardiman J, Davis E, Blough R, Golomb H, Rowley J (1986). «Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7». J Clin Oncol 4 (3): 325–45. PMID 3950675.
Thirman M, Gill H, Burnett R, Mbangkollo D, McCabe N, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg A (1993). «Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations». N Engl J Med 329 (13): 909–14. doi:10.1056/NEJM199309233291302. PMID 8361504.
Austin H, Delzell E, Cole P (1988). «Benzene and leukemia. A review of the literature and a risk assessment». Am J Epidemiol 127 (3): 419–39. PMID 3277397.
Bizzozero O, Johnson K, Ciocco A (1966). «Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time». N Engl J Med 274 (20): 1095–101. doi:10.1056/NEJM196605192742001. PMID 5932020.
Yoshinaga S, Mabuchi K, Sigurdson A, Doody M, Ron E (2004). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology 233 (2): 313–21. doi:10.1148/radiol.2332031119. PMID 15375227. https://archive.org/details/sim_radiology_2004-11_233_2/page/313.
Horwitz M, Goode EL, Jarvik GP (1996). «Anticipation in familial leukemia». Am. J. Hum. Genet. 59 (5): 990–8. PMID 8900225. PMC 1914843. https://archive.org/details/sim_american-journal-of-human-genetics_1996-11_59_5/page/990. Πλήρες κείμενο στο PMC: 1914843
Crittenden LB (1961). «An interpretation of familial aggregation based on multiple genetic and environmental factors». Ann. N. Y. Acad. Sci. 91 (3): 769–80. doi:10.1111/j.1749-6632.1961.tb31106.x. PMID 13696504. Bibcode: 1961NYASA..91..769C.
Horwitz M (1997). «The genetics of familial leukemia». Leukemia 11 (8): 1347–59. doi:10.1038/sj.leu.2400707. PMID 9264391.
Gunz FW, Veale AM (1969). «Leukemia in close relatives--accident or predisposition?». J. Natl. Cancer Inst. 42 (3): 517–24. PMID 4180615. https://archive.org/details/sim_journal-of-the-national-cancer-institute_1969-03_42_3/page/517.
Evans D, Steward J (1972). «Down's syndrome and leukaemia». Lancet 2 (7790): 1322. doi:10.1016/S0140-6736(72)92704-3. PMID 4117858.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD (Ιούνιος 2007). «Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review». Br. J. Haematol. 137 (5): 387–400. doi:10.1111/j.1365-2141.2007.06566.x. PMID 17488484.
Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999). «The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997». Ann Oncol 10 (12): 1419–32. doi:10.1023/A:1008375931236. PMID 10643532. https://archive.org/details/sim_annals-of-oncology_1999-12_10_12/page/1419.
Amin, H. M.; Yang, Y.; Shen, Y.; Estey, E. H.; Giles, F. J.; Pierce, S. A.; Kantarjian, H. M.; O'Brien, S. M. και άλλοι. (2005). «Having a higher blast percentage in circulation than bone marrow: Clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias». Leukemia 19 (9): 1567–1572. doi:10.1038/sj.leu.2403876. PMID 16049515.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E (1996). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». Br J Haematol 94 (3): 557–73. PMID 8790159. https://archive.org/details/sim_british-journal-of-haematology_1996-09_94_3/page/557.
Fialkow PJ (1976). «Clonal origin of human tumors». Biochim. Biophys. Acta 458 (3): 283–321. doi:10.1016/0304-419X(76)90003-2. PMID 1067873.
Fialkow PJ, Janssen JW, Bartram CR (1 Απριλίου 1991). «Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy» (PDF). Blood 77 (7): 1415–7. PMID 2009365. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205004/http://bloodjournal.hematologylibrary.org/cgi/reprint/77/7/1415. Ανακτήθηκε στις 2011-11-30.
Bonnet D, Dick JE (1997). «Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell». Nat. Med. 3 (7): 730–7. doi:10.1038/nm0797-730. PMID 9212098.
Melnick A, Licht JD (15 Μαΐου 1999). «Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia». Blood 93 (10): 3167–215. PMID 10233871. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217143052/http://bloodjournal.hematologylibrary.org/cgi/content/full/93/10/3167. Ανακτήθηκε στις 2011-11-30.
Bishop J (1997). «The treatment of adult acute myeloid leukemia». Semin Oncol 24 (1): 57–69. PMID 9045305. https://archive.org/details/sim_seminars-in-oncology_1997-02_24_1/page/57.
Weick JK, Kopecky KJ, Appelbaum FR, Head, DR, Kingsbury, LL, Balcerzak, SP, Bickers, JN, Hynes, HE και άλλοι. (15 Οκτωβρίου 1996). «A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study» (PDF). Blood 88 (8): 2841–51. PMID 8874180. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205009/http://bloodjournal.hematologylibrary.org/cgi/reprint/88/8/2841. Ανακτήθηκε στις 2011-11-30.
Bishop JF, Matthews JP, Young GA, Szer, J, Gillett, A, Joshua, D, Bradstock, K, Enno, A και άλλοι. (1 Μαρτίου 1996). «A randomized study of high-dose cytarabine in induction in acute myeloid leukemia» (PDF). Blood 87 (5): 1710–7. PMID 8634416. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-04-21. https://web.archive.org/web/20090421123351/http://bloodjournal.hematologylibrary.org/cgi/reprint/87/5/1710. Ανακτήθηκε στις 2011-11-30.
Huang ME, Ye YC, Chen SR, Chai, JR, Lu, JX, Zhoa, L, Gu, LJ, Wang, ZY (1 Αυγούστου 1988). «Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia» (PDF). Blood 72 (2): 567–72. PMID 3165295. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204959/http://bloodjournal.hematologylibrary.org/cgi/reprint/72/2/567. Ανακτήθηκε στις 2011-11-30.
Tallman MS, Andersen JW, Schiffer CA, Appelbaum, Frederick R., Feusner, James H., Ogden, Angela, Shepherd, Lois, Willman, Cheryl και άλλοι. (1997). «All-trans-retinoic acid in acute promyelocytic leukemia». N. Engl. J. Med. 337 (15): 1021–8. doi:10.1056/NEJM199710093371501. PMID 9321529. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-25. https://web.archive.org/web/20090925093142/http://content.nejm.org/cgi/content/full/337/15/1021. Ανακτήθηκε στις 2011-11-30.
Fenaux P, Chastang C, Chevret S, Sanz, M, Dombret, Η, Archimbaud, E, Fey, M, Rayon, C και άλλοι. (15 Αυγούστου 1999). «A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group». Blood 94 (4): 1192–200. PMID 10438706. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-10-31. https://web.archive.org/web/20101031140014/http://bloodjournal.hematologylibrary.org/cgi/content/full/94/4/1192. Ανακτήθηκε στις 2011-11-30.
Estey E (2002). «Treatment of acute myelogenous leukemia». Oncology (Williston Park) 16 (3): 343–52, 355–6; discussion 357, 362, 365–6. PMID 15046392.
Cassileth P, Harrington D, Hines J, Oken M, Mazza J, McGlave P, Bennett J, O'Connell M (1988). «Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia». J Clin Oncol 6 (4): 583–7. PMID 3282032.
Cassileth PA, Harrington DP, Hines JD, Oken, MM, Mazza, JJ, McGlave, P, Bennett, JM, O'Connell, MJ (1988). «Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia». J. Clin. Oncol. 6 (4): 583–7. PMID 3282032.
Mayer RJ, Davis RB, Schiffer CA, Berg, Deborah T., Powell, Bayard L., Schulman, Philip, Omura, George A., Moore, Joseph O. και άλλοι. (1994). «Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B». N. Engl. J. Med. 331 (14): 896–903. doi:10.1056/NEJM199410063311402. PMID 8078551.
Appelbaum FR, Baer MR, Carabasi MH, Coutre, SE, Erba, HP, Estey, E, Glenn, MJ, Kraut, EH και άλλοι. (2000). «NCCN Practice Guidelines for Acute Myelogenous Leukemia». Oncology (Williston Park, N.Y.) 14 (11A): 53–61. PMID 11195419.
Brune M, Castaigne S, Catalano J, Gehlsen, K, Ho, AD, Hofmann, WK, Hogge, DE, Nilsson, B και άλλοι. (Ιούλιος 2006). «Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial». Blood 108 (1): 88–96. doi:10.1182/blood-2005-10-4073. PMID 16556892. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-03-25. https://web.archive.org/web/20100325091815/http://bloodjournal.hematologylibrary.org/cgi/content/full/108/1/88. Ανακτήθηκε στις 2011-11-30.
Appelbaum FR (2001). «Editorial: Who should be transplanted for AML?». Leukemia 15 (4): 680–2. doi:10.1038/sj/leu/2402074. PMID 11368380.
Appelbaum FR (2002). «Keynote address: hematopoietic cell transplantation beyond first remission». Leukemia 16 (2): 157–9. doi:10.1038/sj.leu.2402345. PMID 11840278. http://www.nature.com/leu/journal/v16/n2/full/2402345a.html.
Sievers EL, Larson RA, Stadtmauer EA, Estey, E, Löwenberg, B, Dombret, Η, Karanes, C, Theobald, M και άλλοι. (1 Ιουλίου 2001). «Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse». J. Clin. Oncol. 19 (13): 3244–54. PMID 11432892. http://jco.ascopubs.org/cgi/content/full/19/13/3244.
Soignet SL, Frankel SR, Douer D, Tallman, MS, Kantarjian, Η, Calleja, E, Stone, RM, Kalaycio, M και άλλοι. (15 Σεπτεμβρίου 2001). «United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia». J. Clin. Oncol. 19 (18): 3852–60. PMID 11559723. http://jco.ascopubs.org/cgi/content/full/19/18/3852.
Estey E (2001). «Prognostic factors in acute myelogenous leukemia». Leukemia 15 (4): 670–2. doi:10.1038/sj/leu/2402057. PMID 11368376.
Wheatley K, Burnett A, Goldstone A, Gray R, Hann I, Harrison C, Rees J, Stevens R, Walker Η (1999). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». Br J Haematol 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. https://archive.org/details/sim_british-journal-of-haematology_1999-10_107_1/page/69.
Slovak M, Kopecky K, Cassileth P, Harrington D, Theil K, Mohamed A, Paietta E, Willman C, Head D, Rowe J, Forman S, Appelbaum F (15 Δεκεμβρίου 2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164311/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/13/4075. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Grimwade D, Walker Η, Oliver F, Wheatley, K, Harrison, C, Harrison, G, Rees, J, Hann, I και άλλοι. (1 Οκτωβρίου 1998). «The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties». Blood 92 (7): 2322–33. PMID 9746770. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington, DH, Theil, KS, Mohamed, A, Paietta, E, Willman, CL και άλλοι. (2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Thirman M, Larson R (1996). «Therapy-related myeloid leukemia». Hematol Oncol Clin North Am 10 (2): 293–320. doi:10.1016/S0889-8588(05)70340-3. PMID 8707757.
Rowley J, Golomb H, Vardiman J (1 Οκτωβρίου 1981). «Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease». Blood 58 (4): 759–67. PMID 7272506. http://bloodjournal.hematologylibrary.org/cgi/content/full/58/4/759. ^{[νεκρός σύνδεσμος]}
Pedersen-Bjergaard J, Andersen M, Christiansen D, Nerlov C (2002). «Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia». Blood 99 (6): 1909–12. doi:10.1182/blood.V99.6.1909. PMID 1877259. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204955/http://bloodjournal.hematologylibrary.org/cgi/content/full/99/6/1909. Ανακτήθηκε στις 2011-11-28.
Haferlach T, Schoch C, Löffler Η, Gassmann, W, Kern, W, Schnittger, S, Fonatsch, C, Ludwig, WD και άλλοι. (2003). «Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies». J. Clin. Oncol. 21 (2): 256–65. doi:10.1200/JCO.2003.08.005. PMID 12525517. http://jco.ascopubs.org/cgi/content/full/21/2/256.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland C, Serve H, Büchner T, Haferlach T, Hiddemann W (2002). «Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease». Blood 100 (1): 59–66. doi:10.1182/blood.V100.1.59. PMID 12070009. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-15. https://web.archive.org/web/20100515191256/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/1/59. Ανακτήθηκε στις 2011-11-28.
Gale RE, Hills R, Kottaridis PD, Srirangan, S, Wheatley, K, Burnett, AK, Linch, DC (2005). «No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials». Blood 106 (10): 3658–65. doi:10.1182/blood-2005-03-1323. PMID 16076872. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-02-09. https://web.archive.org/web/20110209110028/http://bloodjournal.hematologylibrary.org/cgi/content/full/106/10/3658. Ανακτήθηκε στις 2011-11-28.
Thornton KA, Levis M (2007). «Images in clinical medicine. FLT3 Mutation and acute myelogenous leukemia with leukostasis». N. Engl. J. Med. 357 (16): 1639. doi:10.1056/NEJMicm064764. PMID 17942876.
Paschka P, Marcucci G, Ruppert AS, Mrózek, K, Chen, Η, Kittles, RA, Vukosavljevic, T, Perrotti, D και άλλοι. (2006). «Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study». J. Clin. Oncol. 24 (24): 3904–11. doi:10.1200/JCO.2006.06.9500. PMID 16921041. http://jco.ascopubs.org/cgi/content/full/24/24/3904.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus, Hillard M., Rowe, Jacob M., Paietta, Elisabeth, Willman, Cheryl, Hurd, David D. και άλλοι. (1998). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». N. Engl. J. Med. 339 (23): 1649–56. doi:10.1056/NEJM199812033392301. PMID 9834301. Αρχειοθετήθηκε από το πρωτότυπο στις 2003-02-12. https://web.archive.org/web/20030212235731/http://content.nejm.org/cgi/content/full/339/23/1649. Ανακτήθηκε στις 2011-11-28.
Matthews JP, Bishop JF, Young GA, Juneja, S. K., Lowenthal, R. M., Garson, O. M., Cobcroft, R. G., Dodds, A. J. και άλλοι. (2001). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». Br. J. Haematol. 113 (3): 727–36. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. https://archive.org/details/sim_british-journal-of-haematology_2001-06_113_3/page/727.
Sanz MA, Lo Coco F, Martín G, Avvisati, G, Rayón, C, Barbui, T, Díaz-Mediavilla, J, Fioritoni, G και άλλοι. (15 Αυγούστου 2000). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood 96 (4): 1247–53. PMID 10942364. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-27. https://web.archive.org/web/20100527064934/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/4/1247. Ανακτήθηκε στις 2011-11-28.
Leone G, Mele L, Pulsoni A, Equitani F, Pagano L (1 Οκτωβρίου 1999). «The incidence of secondary leukemias». Haematologica 84 (10): 937–45. PMID 10509043. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-02. https://web.archive.org/web/20111002154823/http://www.haematologica.org/cgi/reprint/84/10/937. Ανακτήθηκε στις 2011-11-30.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA Cancer J Clin 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-07-06. https://web.archive.org/web/20100706234501/http://caonline.amcancersoc.org/cgi/content/full/51/1/15. Ανακτήθηκε στις 2011-11-30.
Bhatia S, Neglia JP (1995). «Epidemiology of childhood acute myelogenous leukemia». J. Pediatr. Hematol. Oncol. 17 (2): 94–100. doi:10.1097/00043426-199505000-00002. PMID 7749772.
Zhen-yi, Wang (2003). «Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis». Hematology 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-03. https://web.archive.org/web/20111003222949/http://asheducationbook.hematologylibrary.org/cgi/content/full/2003/1/1. Ανακτήθηκε στις 2011-11-28.
Ley TJ, Mardis ER, Ding L, Fulton, Bob, McLellan, Michael D., Chen, Ken, Dooling, David, Dunford-Shore, Brian H. και άλλοι. (2008). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature 456 (7218): 66–72. doi:10.1038/nature07485. PMID 18987736. PMC 2603574. Bibcode: 2008Natur.456...66L. http://www.nature.com/nature/journal/v456/n7218/abs/nature07485.html.
Shapira T, Pereg D, Lishner M (Σεπτέμβριος 2008). «How I treat acute and chronic leukemia in pregnancy». Blood Rev. 22 (5): 247–59. doi:10.1016/j.blre.2008.03.006. PMID 18472198.

pubmedcentral.nih.gov

Horwitz M, Goode EL, Jarvik GP (1996). «Anticipation in familial leukemia». Am. J. Hum. Genet. 59 (5): 990–8. PMID 8900225. PMC 1914843. https://archive.org/details/sim_american-journal-of-human-genetics_1996-11_59_5/page/990. Πλήρες κείμενο στο PMC: 1914843
Ley TJ, Mardis ER, Ding L, Fulton, Bob, McLellan, Michael D., Chen, Ken, Dooling, David, Dunford-Shore, Brian H. και άλλοι. (2008). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature 456 (7218): 66–72. doi:10.1038/nature07485. PMID 18987736. PMC 2603574. Bibcode: 2008Natur.456...66L. http://www.nature.com/nature/journal/v456/n7218/abs/nature07485.html.

web.archive.org

Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA Cancer J Clin 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-01-28. https://web.archive.org/web/20110128054629/http://caonline.amcancersoc.org/cgi/content/full/52/1/23. Ανακτήθηκε στις 2011-11-27.
Vardiman JW, Harris NL, Brunning RD (2002). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood 100 (7): 2292–302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217161643/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/7/2292. Ανακτήθηκε στις 2011-11-28.
Fialkow PJ, Janssen JW, Bartram CR (1 Απριλίου 1991). «Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy» (PDF). Blood 77 (7): 1415–7. PMID 2009365. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205004/http://bloodjournal.hematologylibrary.org/cgi/reprint/77/7/1415. Ανακτήθηκε στις 2011-11-30.
Melnick A, Licht JD (15 Μαΐου 1999). «Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia». Blood 93 (10): 3167–215. PMID 10233871. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-12-17. https://web.archive.org/web/20091217143052/http://bloodjournal.hematologylibrary.org/cgi/content/full/93/10/3167. Ανακτήθηκε στις 2011-11-30.
Acute myeloid leukemia Αρχειοθετήθηκε 2009-09-26 στο Wayback Machine. at Mount Sinai Hospital
Weick JK, Kopecky KJ, Appelbaum FR, Head, DR, Kingsbury, LL, Balcerzak, SP, Bickers, JN, Hynes, HE και άλλοι. (15 Οκτωβρίου 1996). «A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study» (PDF). Blood 88 (8): 2841–51. PMID 8874180. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923205009/http://bloodjournal.hematologylibrary.org/cgi/reprint/88/8/2841. Ανακτήθηκε στις 2011-11-30.
Bishop JF, Matthews JP, Young GA, Szer, J, Gillett, A, Joshua, D, Bradstock, K, Enno, A και άλλοι. (1 Μαρτίου 1996). «A randomized study of high-dose cytarabine in induction in acute myeloid leukemia» (PDF). Blood 87 (5): 1710–7. PMID 8634416. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-04-21. https://web.archive.org/web/20090421123351/http://bloodjournal.hematologylibrary.org/cgi/reprint/87/5/1710. Ανακτήθηκε στις 2011-11-30.
Huang ME, Ye YC, Chen SR, Chai, JR, Lu, JX, Zhoa, L, Gu, LJ, Wang, ZY (1 Αυγούστου 1988). «Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia» (PDF). Blood 72 (2): 567–72. PMID 3165295. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204959/http://bloodjournal.hematologylibrary.org/cgi/reprint/72/2/567. Ανακτήθηκε στις 2011-11-30.
Tallman MS, Andersen JW, Schiffer CA, Appelbaum, Frederick R., Feusner, James H., Ogden, Angela, Shepherd, Lois, Willman, Cheryl και άλλοι. (1997). «All-trans-retinoic acid in acute promyelocytic leukemia». N. Engl. J. Med. 337 (15): 1021–8. doi:10.1056/NEJM199710093371501. PMID 9321529. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-25. https://web.archive.org/web/20090925093142/http://content.nejm.org/cgi/content/full/337/15/1021. Ανακτήθηκε στις 2011-11-30.
Fenaux P, Chastang C, Chevret S, Sanz, M, Dombret, Η, Archimbaud, E, Fey, M, Rayon, C και άλλοι. (15 Αυγούστου 1999). «A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group». Blood 94 (4): 1192–200. PMID 10438706. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-10-31. https://web.archive.org/web/20101031140014/http://bloodjournal.hematologylibrary.org/cgi/content/full/94/4/1192. Ανακτήθηκε στις 2011-11-30.
Brune M, Castaigne S, Catalano J, Gehlsen, K, Ho, AD, Hofmann, WK, Hogge, DE, Nilsson, B και άλλοι. (Ιούλιος 2006). «Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial». Blood 108 (1): 88–96. doi:10.1182/blood-2005-10-4073. PMID 16556892. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-03-25. https://web.archive.org/web/20100325091815/http://bloodjournal.hematologylibrary.org/cgi/content/full/108/1/88. Ανακτήθηκε στις 2011-11-30.
Slovak M, Kopecky K, Cassileth P, Harrington D, Theil K, Mohamed A, Paietta E, Willman C, Head D, Rowe J, Forman S, Appelbaum F (15 Δεκεμβρίου 2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164311/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/13/4075. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Grimwade D, Walker Η, Oliver F, Wheatley, K, Harrison, C, Harrison, G, Rees, J, Hann, I και άλλοι. (1 Οκτωβρίου 1998). «The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties». Blood 92 (7): 2322–33. PMID 9746770. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington, DH, Theil, KS, Mohamed, A, Paietta, E, Willman, CL και άλλοι. (2000). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood 96 (13): 4075–83. PMID 11110676. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-01-30. https://web.archive.org/web/20100130014647/http://bloodjournal.hematologylibrary.org/cgi/content/full/92/7/2322. Ανακτήθηκε στις 2011-11-28.
Byrd J, Mrózek K, Dodge R, Carroll A, Edwards C, Arthur D, Pettenati M, Patil S, Rao K, Watson M, Koduru P, Moore J, Stone R, Mayer R, Feldman E, Davey F, Schiffer C, Larson R, Bloomfield C (2002). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood 100 (13): 4325–36. doi:10.1182/blood-2002-03-0772. PMID 12393746. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-04-10. https://web.archive.org/web/20100410164540/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/13/4325. Ανακτήθηκε στις 2011-11-28.
Pedersen-Bjergaard J, Andersen M, Christiansen D, Nerlov C (2002). «Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia». Blood 99 (6): 1909–12. doi:10.1182/blood.V99.6.1909. PMID 1877259. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-09-23. https://web.archive.org/web/20090923204955/http://bloodjournal.hematologylibrary.org/cgi/content/full/99/6/1909. Ανακτήθηκε στις 2011-11-28.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland C, Serve H, Büchner T, Haferlach T, Hiddemann W (2002). «Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease». Blood 100 (1): 59–66. doi:10.1182/blood.V100.1.59. PMID 12070009. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-15. https://web.archive.org/web/20100515191256/http://bloodjournal.hematologylibrary.org/cgi/content/full/100/1/59. Ανακτήθηκε στις 2011-11-28.
Gale RE, Hills R, Kottaridis PD, Srirangan, S, Wheatley, K, Burnett, AK, Linch, DC (2005). «No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials». Blood 106 (10): 3658–65. doi:10.1182/blood-2005-03-1323. PMID 16076872. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-02-09. https://web.archive.org/web/20110209110028/http://bloodjournal.hematologylibrary.org/cgi/content/full/106/10/3658. Ανακτήθηκε στις 2011-11-28.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus, Hillard M., Rowe, Jacob M., Paietta, Elisabeth, Willman, Cheryl, Hurd, David D. και άλλοι. (1998). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». N. Engl. J. Med. 339 (23): 1649–56. doi:10.1056/NEJM199812033392301. PMID 9834301. Αρχειοθετήθηκε από το πρωτότυπο στις 2003-02-12. https://web.archive.org/web/20030212235731/http://content.nejm.org/cgi/content/full/339/23/1649. Ανακτήθηκε στις 2011-11-28.
Sanz MA, Lo Coco F, Martín G, Avvisati, G, Rayón, C, Barbui, T, Díaz-Mediavilla, J, Fioritoni, G και άλλοι. (15 Αυγούστου 2000). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood 96 (4): 1247–53. PMID 10942364. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-05-27. https://web.archive.org/web/20100527064934/http://bloodjournal.hematologylibrary.org/cgi/content/full/96/4/1247. Ανακτήθηκε στις 2011-11-28.
Leone G, Mele L, Pulsoni A, Equitani F, Pagano L (1 Οκτωβρίου 1999). «The incidence of secondary leukemias». Haematologica 84 (10): 937–45. PMID 10509043. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-02. https://web.archive.org/web/20111002154823/http://www.haematologica.org/cgi/reprint/84/10/937. Ανακτήθηκε στις 2011-11-30.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA Cancer J Clin 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. Αρχειοθετήθηκε από το πρωτότυπο στις 2010-07-06. https://web.archive.org/web/20100706234501/http://caonline.amcancersoc.org/cgi/content/full/51/1/15. Ανακτήθηκε στις 2011-11-30.
Zhen-yi, Wang (2003). «Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis». Hematology 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. Αρχειοθετήθηκε από το πρωτότυπο στις 2011-10-03. https://web.archive.org/web/20111003222949/http://asheducationbook.hematologylibrary.org/cgi/content/full/2003/1/1. Ανακτήθηκε στις 2011-11-28.